Posts by Sumit Ruecker

North America Ruxolitinib Market size was valued at USD 0.9 Billion in 2022 and is projected to reach USD 2.1 Billion by 2030, growing at a CAGR of 11.5% from…

North America Targeted Drug EGFR RTK Inhibitors for NSCLC Market size was valued at USD 3.2 Billion in 2022 and is projected to reach USD 5.8 Billion by 2030, growing…

North America Durvalumab Market size was valued at USD 1.5 Billion in 2022 and is projected to reach USD 3.0 Billion by 2030, growing at a CAGR of 9.5% from…

North America Allisartan Isoproxil Market size was valued at USD 0.2 Billion in 2022 and is projected to reach USD 0.4 Billion by 2030, growing at a CAGR of 8.5%…

North America Crizotinib Market size was valued at USD 0.7 Billion in 2022 and is projected to reach USD 1.4 Billion by 2030, growing at a CAGR of 9.1% from…

North America Targeted Drug BRAF Inhibitors for NSCLC Market size was valued at USD 0.7 Billion in 2022 and is projected to reach USD 1.5 Billion by 2030, growing at…

North America Targeted Drugs for NSCLC Market size was valued at USD 4.2 Billion in 2022 and is projected to reach USD 7.0 Billion by 2030, growing at a CAGR…

North America Dolutegravir Market size was valued at USD 2.0 Billion in 2022 and is projected to reach USD 3.6 Billion by 2030, growing at a CAGR of 7.5% from…

North America Sofosbuvir/Ledipasvir Compound Drugs Market size was valued at USD 2.0 Billion in 2022 and is projected to reach USD 3.2 Billion by 2030, growing at a CAGR of…

North America Osimertinib Market size was valued at USD 1.5 Billion in 2022 and is projected to reach USD 4.3 Billion by 2030, growing at a CAGR of 15.6% from…